相关实验视频

Updated: Jul 1, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

高风险局部晚期宫癌患者的特征,治疗模式和结果

Francesca Coutinho¹, Mugdha Gokhale², Charlotte Doran¹

¹ConcertAI, LLC, 1120 Massachusetts, Ave., Cambridge, MA 02138, USA.

Cancer treatment and research communications

|March 2, 2024

概括

大多数高风险局部晚期宫癌 (HR-LACC) 患者接受并发化疗放射治疗 (CCRT). 在CCRT后的持续性疾病强调了对HR-LACC更好的初始治疗和维护策略的需要.

科学领域:

在瘤学瘤学.
妇科瘤学妇科瘤学
临床研究临床研究

背景情况:

高风险局部晚期宫癌 (HR-LACC) 是一个重大的临床挑战.
了解现实世界的治疗模式对于改善患者的治疗结果至关重要.

研究的目的:

描述HR-LACC患者的现实世界治疗模式和结果.
评估初始治疗的有效性,特别是并发化学放射治疗 (CCRT).

主要方法:

在2010年至2018年间诊断出HR-LACC的300名成年患者的回顾性分析.
使用Kaplan-Meier方法来估计现实世界无进展生存率 (rwPFS) 和无复发生存率 (rwRFS).
分析的重点是最初用CCRT治疗的患者.

主要成果:

同时化疗放射治疗 (CCRT) 是大多数HR-LACC患者的主要初始治疗 (N=229).
在CCRT后患有持续性疾病的患者中,中位数rwPFS为29.7个月.
显著的比例的患者经历了复发或持续的疾病,表明当前的CCRT方法的局限性.

结论:

同时化疗放射治疗 (CCRT) 是美国高风险局部晚期宫癌 (HR-LACC) 的标准初始治疗方法.
有相当数量的患者在CCRT后发展出持久性疾病,这强调了对新型治疗策略的需求.
改进的第一线治疗和维持疗法对于管理HR-LACC至关重要.

关键词:

化学疗法或放射疗法医疗记录医疗记录医疗记录当地当地当地当地当地新生体复发的发生.个人个人个人个人追溯研究是回顾性研究.子宫瘤是什么?子宫瘤是什么?

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...